Research never stops

Top Story

Evotec enters innovative research initiative with Gladstone Institutes and Dolby Family Ventures in Alzheimer's Disease

San Francisco, USA; Hamburg, Germany - 24 July 2015: Evotec AG today announced that it has become part of a research initiative between a newly established for-profit company of the Gladstone Institutes called Cure Network Ventures, Inc. and Dolby Family Ventures.

- read more

Evotec's partner Roche provides initial update from Phase IIb trial in Alzheimer's disease

Hamburg, Germany - 30 June 2015: Evotec AG was updated today by its partner Roche on the initial results of the Phase IIb trial with Sembragiline, a MAO-B inhibitor for the treatment of Alzheimer's disease.

- read more

Evotec’s approach to phenotypic screening

On the 11 June 2015 at 3 pm GMT (10 am EDT; 4 pm CET) in a free webinar, York Rudhard, Principal Scientist, and Mike Bodkin, VP Research Informatics at Evotec will provide insights into Evotec’s approach to phenotypic screening

To register and join the discussion, please click here

- read more
loading weather report
Loading weather report...


Sep 15, 2015 - BioPharm America 2015

Sep 16, 2015 - Morgan Stanley Global Healthcare Conference

Company Presentation July

Building integrated and high-value drug discovery alliances
2015-07_Evotec_Company presentation_July